OGT Releases New Whitepaper for Aiding Biomarker Discovery
News Jan 24, 2012
Oxford Gene Technology (OGT) has released a new whitepaper entitled ‘Autoantibody biomarker panels for improved disease diagnosis’. The free-to-download document explores the need for biomarkers as indicators of disease, and discusses the vast potential of autoantibodies as markers of early disease development.
Autoantibodies are produced by the host immune system and as such are often detectable during the early stages of disease onset. In addition, they are stable, abundant, highly specific and easily purified from serum, making them ideal candidates for use in disease detection. The issues surrounding the use of autoantibodies as biomarkers are discussed in detail in the whitepaper, including their relative advantages, selection of the most appropriate discovery technology and choosing between strategies for in-house or outsourced discovery.